Latest release of Philips Capsule Surveillance receives FDA clearance
March 15 2022 - 8:00AM
Latest release of Philips Capsule Surveillance receives FDA
clearance
March 15, 2022
- Clinical surveillance solution is designed to identify emergent
patient deterioration and offer enhanced patient data visibility,
flexible viewing options, and clinical decision support
- Facilitates remote patient oversight at mobile, eICU and
virtual care clinical touchpoints
- New FDA clearance covers additional use cases and information
access methods
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology,
announced today at HIMSS22 that the latest Philips Capsule
Surveillance solution has received 510(k) market clearance from the
U.S. Food & Drug Administration (FDA), paving the way for
widespread deployment across healthcare systems in the USA.
Capable of utilizing streaming data from virtually any connected
medical device, the solution aggregates patient data, analyses it
to generate actionable insights and alerts, and sends timely
notifications to the patient’s caregivers so that they can
intervene before deterioration progresses further. This latest
release of Philips Capsule Surveillance includes expanded
interoperability into hospitals’ existing mobile clinical
communication and collaboration tools and electronic intensive care
units (eICUs) and virtual care population health management
systems, offering more visibility on live streaming data,
waveforms, device alarms and contextual alerts.
“This FDA clearance of the latest release of clinical
surveillance solution enables more integrated viewing options
within EMR and HIT tools through the secure web-based user
interface. The updated intended use provides flexible
deployment configurations that Philips Capsule can offer to
hospitals and health systems in the USA,” said Elad Benjamin,
general manager of Clinical Data Services at Philips. “Properly
implemented clinical surveillance has the potential to
significantly improve patient outcomes by helping to avoid
deterioration, while also improving the care team experience via
clinical decision support and minimizing the burden of false and
clinically unactionable alarms.”
Enhanced data visibility at eICU and virtual care
locationsPhilips Capsule Surveillance offers an
enterprise-wide solution that complements eICU telehealth command
center solutions, such as Philips eCareManager, by bringing
together live-streaming patient data across multiple acuity
settings, equipment brands and device types to show each patient’s
immediate status.
Smart rule clinical decision supportBuilt on
the vendor-neutral Philips Capsule Medical Device Information
Platform, which captures and normalizes streaming data from a
network of connected devices, the Philips Capsule Surveillance
software continuously analyzes patient data using patented
technology to identify deteriorating conditions and critical
events. The software applies a set of smart rules based on clinical
parameters and current best-practice guidelines that can be
tailored to an individual hospital’s protocols for specific
morbidities.
Philips Capsule Surveillance allows clinicians to see patient
data and patient monitor settings and alarms from multiple device
types without needing to enter the patient’s room. When caring for
infectious patients, this can help reduce the risk to clinical
staff. Early identification of deteriorating patient conditions can
also help to avoid complications and escalations, contributing to
lower cost of care, while the ability to remotely monitor large
numbers of patients and focus resources where needed can help
mitigate the shortage of experienced clinicians.
The latest version of Philips Capsule Surveillance will be
released in Q2 to limited sites in the USA. For more information,
visit https://capsuletech.com/capsule-clinical-surveillance.
For more information on Philips’ full portfolio of connected
care solutions being showcased in booth #2501 at the HIMSS22 Global
Health Conference & Exhibition, please visit
www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS22
updates throughout the event.
For further information, please contact:
Meredith AmorosoPhilips Global Press Office Mobile: +1 724 584
8991E-mail: meredith.amoroso@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2021 sales of EUR 17.2 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- A nurse reviews patient data via Philips Capsule
Surveillance
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024